Skip to content

Sleep Health Enhancement in Midlife Adults

Sleep Health Enhancement in Midlife Adults

Status
Completed
Phases
Phase 1Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06311500
Enrollment
30
Registered
2024-03-15
Start date
2024-02-13
Completion date
2025-11-19
Last updated
2025-12-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Midlife Adults, Sleep Health

Brief summary

Despite the strong links between sleep and AD, a sleep health enhancement has yet to be targeted in mid-life adults (45-64 years old) to delay or prevent AD. An intervention aimed at enhancing sleep health is a critical opportunity for primary prevention to potentially delay the onset of AD. The objective of the proposed study is to develop and assess the feasibility, acceptability, and treatment effect of a comprehensive sleep health intervention (SHI) on improving sleep health in mid-life adults

Interventions

4 weekly visits of education and strategies to enhance sleep health

Sponsors

University of Kansas Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
45 Years to 64 Years
Healthy volunteers
Yes

Inclusion criteria

* 45-64 years old * ≤ 7 on the RU-SATED self-report questionnaire * MMSE ≥25 and AD8 \<3

Exclusion criteria

* Known untreated sleep disorder (such as sleep apnea or restless leg syndrome) * \>3 on the STOP BANG indicating increased risk of sleep apnea * Increased risk of restless legs syndrome on RLS-Diagnosis Index * Evidence of circadian rhythm sleep-wake disorder * Evidence of parasomnia * Regular use (\>2x/week) of prescription or over-the-counter medications to improve sleep * Score of ≥15 on the Patient Health Questionnaire (PHQ-9) indicating severe depression or endorsement of any suicidal ideation (answer 1, 2 or 3 on #9 of the PHQ-9) * Score of ≥10 on the Generalized Anxiety Disorder (GAD-7) indicating moderate to severe anxiety * Self-report of current or history (up to 2 years) of drug or alcohol abuse based on the DSM-5-TR criteria * History of nervous system disorder such as stroke or Parkinson's disease * Severe mental illness such as schizophrenia or bipolar disorder * Current or history (within 5 years) of shift work including hours of midnight-4am * Is currently receiving a behavioral sleep health intervention

Design outcomes

Primary

MeasureTime frameDescription
Dysfunctional Beliefs About Sleep (DBAS-10) consists of 10 statements reflecting beliefs and attitudes about sleep. Each statement is rated from 1 = strongly disagree to 10 = strongly agreebaseline, Week 6, Week 12The DBAS-10 used to identify dysfunctional beliefs about sleep
Positive Affect and Negative Affect Schedulebaseline, Week 6, Week 1220-item self-report questionnaire used to measure positive and negative emotions
Continuous Performance Testbaseline, Week 6, Week 12requires participants to respond as quickly and accurately as possible to a series of stimuli that are delivered via computer. The participants will be instructed to tap the space bar for every letter except X.
Stroop Testbaseline, Week 6, Week 12requires participants to inhibit the natural response (reading a word) and replace it with another response (saying a color)
6-item Acceptability Scaleimmediately post-intervention5-point Likert scales on ease of use, understandability, enjoyment, perceived helpfulness, time commitment, and overall satisfaction
Qualitative interviewimmediately post-interventionsemi-structured interview to assess acceptability
Ru-SATED Composite scorebaseline, Week 6, Week 12Comprised of 6 subscores (regularity, timing, efficiency, and duration from actigraphy, satisfaction from sleep diary, and alertness from Epworth Sleepiness Scale)
Sleep Self-Efficacy Scalebaseline, Week 6, Week 129 item self-report Likert-scale questionnaire use to identify sleep self-efficacy.
Pittsburgh Sleep Quality Indexbaseline, Week 6, Week 12used to assess quality of sleep
Epworth Sleepiness Scalebaseline, Week 6, Week 12used to assess daytime sleepiness
Cognitive Failures Questionnairebaseline, Week 6, Week 12assesses perception of cognitive abilities over the past 6 months
Actigraphybaseline, Week 6, Week 12Participants will wear an actigraph on their non-dominant wrist for 7 nights to assess sleep/wake cycle. Mains variables of interest are sleep regularity, timing, efficiency, and duration.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026